Recommendations for Quicker CTA Negotiation
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…
Overcome Today’s New Enrollment Challenges
Choose Your Specialized CRO Partner Well The global clinical trials market is expected to reach $69.8 billion US by 2027,…
Overcome Oncology Clinical Trial Obstacles – 2019 Real World Evidence for 2020 and Beyond
Overall the clinical trial market is growing at a robust pace that is expected to continue into 2024, owing to…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do You Believe the Myths About Conducting Clinical Trials in Canada?
Myths exist to explain things we don’t understand, as well as to continue traditions and keep relationships and societies ‘safe’.…
Real World Evidence of a Successful Oncology Trial Rescue in Canada
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…
Centralized Ethics Review for Oncology Trials in Canada – An interview with Janet Manzo, Executive Director, Ontario Cancer Research Ethics Board
In this interview Janet Manzo, Executive Director of the Ontario Cancer Research Ethics Board, discusses the development of a province-wide…
Proven Approach to Site Selection is Attracting More Cutting-Edge Oncology Trials to Canada
12 Early-Phase Oncology Programs Started-Up in Canada Over Last 18-Months
Scimega Oncology, (www.scimega.com) the company behind the revolutionary Reverse Feasibility Program, announced it has been awarded